2018 CORE Agenda
What is Google Doing in Life Science?
Luba Greenwood, Strategic BusinessDevelopment and Corporate Ventures at Google, Verily
Being Diagnosed with Stage 4 Melanoma and Trying to Find a Clinical Trial: One Patient’s Perspective
T.J. Sharpe, Patient #1, Generously Supported by Inspire
Risk Management a Year Later: How We Should Be Managing Risk in a Comprehensive Fashion?
Jonathan Rowe PhD, MS, MA Executive Director, Head of Quality Performance and Risk Management, Pfizer,
Rita Amirana, Senior Director, Head of Clinical Programs, Synlogic
Linda Sullivan, Metrics Champion Consortium
What is Brexit going to change in Clinical Research?
Ross Pettit, Vice President, Clinical Development Operations H3 Biomedicine
Patient Centric Protocols and Advocacy Groups
Paulo Moreira, formerly Vice President, Global Clinical Operations - External Innovation at EMD Serono, Inc.
New Tufts Research: Challenges and Opportunities for Outsourcing Effectiveness
Rick Morrison, Founder and President, Comprehend
Beth Harper, MBA, President, Clinical Performance Partners
Case Study on A New Model for CRO Engagement: Pay for Performance
Elspeth Carnahan, Vice President Supplier Performance Management, Global Clinical Operations, EMD Serono, Inc.
Tear down those Clinical Data Silos!
Karim Damji, SVP Product Management & Marketing Saama Technologies
The CRO-Less Clinical Trial: Going Completely Paperless
Debbie Profit, VP Information Technology, Otsuka
Workshop: The Talent War, and Options for Using Competency Models as the Talent Development of the Future
Bill Gluck, Ph.D. Program Director, Durham Technical Community College
Beth Harper, Clinical Performance Partners
Real World Evidence & Health Economics Outcomes Research
Francis Kendall, Senior Director Biostatistics & Programming
Peggy Schrammel, Consultant Cytel
GDPR: 5 Months Later
Kyle Faget, Co-chair Life Science Practice at Foley & Lardner LLP
Dana Leff Niedzielska, CEO, August Research
Leadership: Taking Your Career to the Next Level
Lisa Prior, Founder and CEO, Prior Associates
Supply Chain: How Hard Could It Be?
Melissa Peirsel, Manager, IRT Services at Sharp Clinical Services
New Models that “Break the Mold”
Dina Berdeiva, Head of Project Management & Clinical Operations, The Bill & Melinda Gates Foundation
Heather DiBenedetto, Head of Therapeutic Operations, Moderna Therapeutics
The Future of Drug Development - Drugs, Devices & Diagnostics
Pam Randhawa, Founder & CEO Empiriko